Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AEB071 multiple ascending dose study in moderate to severe chronic plaque psoriasis
2004-003972-12Phase 2Completed
- Sponsor
- Novartis
- Start
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, double-blind trial of sotrastaurin in psoriasis (2 arms), sponsored by Novartis. Primary endpoints: Safety and tolerability and Pharmacokinetics. Started Dec 2004; status: completed.
02
Drugs
sotrastaurin
03
Conditions
psoriasis
Beyond the preview
Go deeper on 2004-003972-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-003972-12.